Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 9 - Medicinal preparations characterised by special physical form
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
12/2012
12/26/2012CN102078302B Method for preparing berbamine chitosan-agar nano particles
12/26/2012CN102078028B Cigarette for benefiting gallbladder, reducing blood pressure and giving up smoking and preparation method thereof
12/26/2012CN102038939B Preparation method of adenosine triphosphate coenzyme insulin freeze-dried powder injection
12/26/2012CN102038638B 盐酸克林霉素注射液及其制备方法 Clindamycin Hydrochloride Injection and its preparation method
12/26/2012CN101953773B Lamivudine liposome solid preparation
12/26/2012CN101939002B Pharmaceutical compositions of entacapone co-micronized with sugar alcohols
12/26/2012CN101934067B Preparation method of polygeline injection
12/26/2012CN101889982B Novel long-circulating liposome composition and preparation method thereof
12/26/2012CN101856419B Chinese medicament Quzhenling liniment for treating infant eczema
12/26/2012CN101837011B Medicinal composition for treating diabetes
12/26/2012CN101820874B Powdered medicament for nasal delivery of ascorbic acid for reducing apomorphine induced toxicity to ciliated tissue
12/26/2012CN101721444B Saussurea involucrate self-micro-emulsion, preparation method thereof and application thereof
12/26/2012CN101703780B Lactic acid-ethanol copolymer microsphere with modified surface and preparation method thereof
12/26/2012CN101687046B Pharmaceutical liquid composition of botulinum toxin with improved stability
12/26/2012CN101637563B Chinese medicinal composition for treating viral myocarditis and preparation process thereof
12/26/2012CN101596225B Anti-tumour traditional Chinese medicine preparation containing glossy ganoderma spore oil and preparation method thereof
12/26/2012CN101590023B Clopidogrel hydrogen sulfate tablet and preparation method thereof
12/26/2012CN101528207B Transdermal therapeutic system for administering the active substance buprenorphine
12/26/2012CN101513526B Application of combined vaccine in treating tumors
12/26/2012CN101342303B Pure natural medicament for treating diabetes
12/26/2012CN101242812B Pancreatin micropellets suitable for enteric coating
12/26/2012CN100998864B Cyclosporin A semisolid skeleton capsule
12/25/2012US8338486 Methods for the treatment of CNS-related conditions
12/25/2012US8338485 Compositions for the treatment of CNS-related conditions
12/25/2012US8338481 Alkoxyalkyl S-prenylthiosalicylates for treatment of cancer
12/25/2012US8338428 Methods for administering aripiprazole
12/25/2012US8338427 Methods for administering aripiprazole
12/25/2012US8338395 Methods and pharmaceutical compositions for reliable achievement of acceptable serum testosterone levels
12/25/2012US8338384 Method for treating ocular neovascularization
12/25/2012US8338374 Storage stability, even after freeze-thaw; aqueous; buffer, stabilizing agents, including a nonionic surfactant (e.g. polysorbate 20), a polymer stabilizer (e.g. polyethylene glycol), and optional stabilizers such as magnesium salts, a tonicity agent, methionine, and a preservative
12/25/2012US8337915 Fenugreek seed extract to lower blood cholesterol
12/25/2012US8337901 Process for the manufacture of cellulose sulfate with improved characteristics
12/25/2012US8337900 Reverse-phase microcapsules for active ingredients, simplified process of manufacture thereof and combined formulation WDG-CS, ZC, EC-SC, and CX
12/25/2012US8337899 Solid pharmaceutical dispersions with enhanced bioavailability
12/25/2012US8337898 Functionalized nanoceria composition for ophthalmic treatment
12/25/2012US8337897 Immediate release pharmaceutical granule compositions and a continuous process for making them
12/25/2012US8337896 Drug-containing nanoparticles
12/25/2012US8337895 Spray drying process control of drying kinetics
12/25/2012US8337893 Sol-gel derived bioactive glass polymer composite
12/25/2012US8337892 Low-dose tablets and preparation method
12/25/2012US8337891 Enteric coated composition comprising prostaglandin analogs as chloride channel opener
12/25/2012US8337890 Modified release formulations containing drug-ion exchange resin complexes
12/25/2012US8337889 Smectite dispersible tablets and the preparation thereof
12/25/2012US8337888 Pharmaceutical formulation containing gelling agent
12/25/2012US8337887 Rapidly disintegrating taste-masked tablet
12/25/2012US8337886 Pellet formulation for the treatment of the intestinal tract
12/25/2012US8337885 capsule medication administration system includes: a first capsule for internal body marking; a second capsule for medication; a marking device which makes a marking within a living body; a drug retention section which retains a drug; a release device which releases the drug; a detection device
12/25/2012US8337884 Transdermal compositions containing low molecular weight drugs which are liquid at room temperatures
12/25/2012US8337883 Transdermal delivery systems
12/25/2012US8337882 Personal stimulating wiping systems
12/25/2012US8337881 For use as wound closure adhesives
12/25/2012US8337877 Reduction of infection associated with medical device
12/25/2012US8337871 Insecticide formulation
12/25/2012US8337868 Stinging cells expressing an exogenous polynucleotide encoding a therapeutic, diagnostic or a cosmetic agent and methods compositions and devices utilizing such stinging cells or capsules derived therefrom for delivering the therapeutic, diagnostic or cosmetic agent into a tissue
12/25/2012US8337867 Metal lactate powder and method for preparation
12/25/2012US8337826 Active ingredient in a concentrate and a buffer; storage stability; free from human serum albumin
12/25/2012US8337823 Modified macromolecule
12/25/2012US8337817 Preparation for transnasal application
12/25/2012US8337816 Comprising inhalable medicament particles having a mass median aerodynamic diameter no greater than 10 mu m and 50% of a non-respirable excipient fraction comprising low density excipient particles having an aerodynamic diameter greater than 10 mu m and a geometric diameter greater than 30 mu m
12/25/2012US8337815 Pulmonary surfactant formulations
12/25/2012US8337814 Treatment of active infections, sinusitis, rhinitis, and related neurological disorders and related compositions
12/25/2012US8337548 Implant and system of an implant and an excitation device
12/25/2012US8337488 Diaphragm drug pump
12/25/2012US8337487 Reticulated elastomeric matrices, their manufacture and use in implantable devices
12/25/2012US8337486 Energy supply for fluid dispensing device
12/25/2012US8337445 Ocular implant with double anchor mechanism
12/20/2012WO2012174559A1 Inhalable pharmaceutical compositions
12/20/2012WO2012174556A1 High capacity diketopiperazine microparticles
12/20/2012WO2012174555A2 Composition and method for stabilization and delivery of therapeutic molecules
12/20/2012WO2012174472A1 High capacity diketopiperazine microparticles
12/20/2012WO2012174436A1 Nuclear receptor modulators and their use for the treatment and prevention of cancer
12/20/2012WO2012174262A2 Formulations and methods of treating subjects having central nervous system, endocrine, inflammatory or cardiovascular disorders or at-risk thereof with highly purified omega-3 fatty acid formulations
12/20/2012WO2012173933A2 Activatable nanoprobes for intracellular drug delivery
12/20/2012WO2012173877A1 Pharmaceutical compositions of combinations of dipeptidyl peptidase-4 inhibitors with simvastatin
12/20/2012WO2012173621A1 Multi-layer capsule and manufacture method thereof
12/20/2012WO2012173587A1 Sugar-free chewable supplement
12/20/2012WO2012173288A1 Magnetic resonance imaging t2 contrast medium for cell contrasting, and method for manufacturing same
12/20/2012WO2012173226A1 Pharmaceutical preparation containing polystyrenesulfonic acid salt
12/20/2012WO2012173003A2 Medical tissue-marker and manufacturing method for same
12/20/2012WO2012172821A1 Therapeutic agent for allergic rhinitis
12/20/2012WO2012172461A1 Pharmaceutical compositions of febuxostat
12/20/2012WO2012172457A1 Novel lipidomimetic compounds and uses thereof
12/20/2012WO2012172433A2 A sustained-release composition containing peptides as active ingredient
12/20/2012WO2012172413A1 Pharmaceutical composition comprising a combination of eperisone and diclofenac and process for preparing thereof
12/20/2012WO2012172243A1 Distribution device and production method thereof
12/20/2012WO2012172192A1 Iodinated fatty acid esters containing a minimum of 50 percent of monoiodostearic acid esters or derivatives in the form of a soft capsule or a gel capsule, of use during a nuclear accident
12/20/2012WO2012171920A1 Treatment device
12/20/2012WO2012171884A1 Gastric resistant pharmaceutical or nutraceutical composition with resistance against the influence of ethanol
12/20/2012WO2012171576A1 Coating composition suitable for pharmaceutical or nutraceutical dosage forms
12/20/2012WO2012171575A1 Coating composition suitable for pharmaceutical or nutraceutical dosage forms
12/20/2012WO2012171561A1 Stabilized voriconazole composition
12/20/2012WO2012171540A1 Suppository comprising pantoprazole comprised in pellets with a cellulose core
12/20/2012WO2012171364A1 Oil-soluble pharmaceutical composition
12/20/2012WO2012171335A1 Multi-vinylsulfone containing molecule
12/20/2012WO2012171084A1 Polymer insulin encapsulation system, process and use of said system
12/20/2012WO2012148181A3 Composition for the controlled-release of drugs
12/20/2012WO2012136934A3 Healing composition for topical application
12/20/2012WO2012119780A3 Novel lipids and novel phospholipids structures
12/20/2012WO2012102538A3 Dry syrup composition
12/20/2012WO2012021419A3 Oral compositions comprising a zinc compound
1 ... 385 386 387 388 389 390 391 392 393 394 395 396 397 398 399 400 401 402 403 404 405 ... 2991